Our study showed the level of VEGF-A in the aqueous of AMD and RVO groups to be higher than that in the control group, which also identified the role of VEGF in the pathogenesis of AMD and RVO, and the necessity of anti-VEGF treatment. The gene discussed is VEGFA; the disease is age-related macular degeneration.